The purpose of this study is to design and Beta test the Life at 100.4, an immersive social virtual reality education tool, with an anticipated 5 patient-caregiver-provider triads.Patients at Yale Pediatric Hematology and Oncology with a new oncologic diagnosis and their caregivers will be eligible for enrollment. Investigators will determine the feasibility and acceptability of implementing Life at 100.4 using validated measures.
Newly diagnosed with a malignancy or bone marrow failure condition
Planned to receive chemotherapy and receive a central line
Medical contraindication to virtual reality including head wounds and history of seizure with flashing lights
No plan to receive chemotherapy
Parallel
Life at 100.4
BehavioralAn Immersive Social Virtual Reality Education Tool, participation up to 2 hours
Multimodal Presence Scale for Virtual Environments
A 15-item validated tool to assess presence in VR. There are five items for each of the three dimensions, Physical Presence, Social Presence, and Self-Presence, scored on a 5-point Likert scale, from 1 (strongly disagree) to 5 (strongly agree). Total score for each dimension 1-5 with higher scores indicating a stronger sense of presence in that dimension.
System Usability Scale (SUS)
A 10-item questionnaire with responses provided on a Likert scale. The SUS has been applied in evaluating the usability of different websites, software, and human computer interfaces. The final score is on a scale of 0-100. Higher scores indicate more usability.
Technology Acceptance Model (TAC)
Technology Acceptance Model questionnaire with questions related to Perceived Usefulness and Perceived Ease of Use. Total score range 1-5 with higher scores indicating higher acceptance and use.
Click on the lead sponsor to view all of their trials.
Yale University
Lead sponsor
The Glimpse Group Inc
Collaborator
National Institute of Nursing Research (NINR)
Collaborator
